influenza-like illness respiratory tract infections
Conditions
Interventions
During this study no intervention will take place. Participants if this study
also participate in the CAPiTA trial, a double-blind vaccination trial during
which they received either a 13-valent pne
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. participation in the CAPITA study 2. able to fill in an internet-based questionnaire
Exclusion criteria
Exclusion criteria: 1. lost to follow-up or withdrawn from the CAPITA study 2. Residence in a nursing home, long-term care facility or other institution, or requirement of semiskilled nursing care
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: incidence of a first episode of self-reported ILI | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: 1.incidence of self-reported LRTI 2.proportion of episodes requiring visit to general practitioner | — |
Countries
Netherlands
Outcome results
None listed